30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Assembly Biosciences Inc (ASMB)

Track

Over the last 90 days, Assembly Biosciences Inc. has seen net insider selling totaling $14,686.6, with executives accounting for all of this activity. There were 5 transactions, all sales, indicating a negative net value. The company's stock has experienced a 14.5% decrease in price over the past 90 days.
Stock chart
Ticker: ASMB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Bjorkquist Jeanette M
PFO and PAO
1 sale — total 100,000 USD
Sale 17 Jun 2026
Value US$591,079.61 | Price 14.44 | Shares 25,396
Sale 30 Mar 2026
Value US$1,690,263.27 | Price 401.12 | Shares 29,762
Sale 30 Mar 2026
Value US$3,662,067.39 | Price 106.07 | Shares 23,372
Sale 30 Mar 2026
Value US$247.41 | Price 27.49 | Shares 9
Sale 30 Mar 2026
Value US$5,010.24 | Price 26.65 | Shares 188
Sale 31 Mar 2025
Value US$7,455.01 | Price 9.85 | Shares 757
Planned sale 31 Mar 2025
Value US$3,496.08 | Price 9.85 | Shares 355
Sale 31 Mar 2025
Value US$1,772.66 | Price 9.85 | Shares 180
Sale 31 Mar 2025
Value US$1,940.08 | Price 9.85 | Shares 197
Buy 30 Dec 2024
Value US$49,997.63 | Price 15.61 | Shares 3,202
Buy 19 Dec 2024
Value US$20,098,463.63 | Price 21.37 | Shares 940,499
Buy 25 Nov 2024
Value US$74,250.00 | Price 14.85 | Shares 5,000
Buy 25 Nov 2024
Value US$44,640.00 | Price 15.00 | Shares 2,976
Buy 22 Nov 2024
Value US$253,104.32 | Price 14.87 | Shares 17,024
Sale 18 Nov 2024
Value US$651.60 | Price 16.29 | Shares 40
Buy 8 Oct 2024
Value US$145,800.00 | Price 14.58 | Shares 10,000
Sale 3 Oct 2024
Value US$2,917.57 | Price 14.81 | Shares 197
Sale 3 Oct 2024
Value US$2,325.17 | Price 14.81 | Shares 157
Sale 2 Aug 2024
Value US$11,172.51 | Price 14.23 | Shares 785
Sale 2 Aug 2024
Value US$13,962.08 | Price 14.23 | Shares 981
Buy 5 Jul 2024
Value US$55,563.76 | Price 12.52 | Shares 4,438
Buy 3 Jul 2024
Value US$56,066.98 | Price 12.29 | Shares 4,562
Sale 23 May 2024
Value US$2,568.61 | Price 14.93 | Shares 172
Planned sale 23 May 2024
Value US$8,198.66 | Price 14.93 | Shares 549
Sale 23 May 2024
Value US$358.41 | Price 14.93 | Shares 24
Sale 23 May 2024
Value US$31,614.85 | Price 14.93 | Shares 2,117
Sale 30 Apr 2024
Value US$19,936.97 | Price 12.71 | Shares 1,569
Sale 30 Apr 2024
Value US$15,947.03 | Price 12.71 | Shares 1,255
Sale 1 Apr 2024
Value US$1,490.20 | Price 13.07 | Shares 114
Sale 1 Apr 2024
Value US$15,764.71 | Price 13.07 | Shares 1,206
Sale 1 Apr 2024
Value US$2,575.16 | Price 13.07 | Shares 197
Sale 1 Apr 2024
Value US$4,627.45 | Price 13.07 | Shares 354
Sale 27 Mar 2024
Value US$5,045.04 | Price 12.87 | Shares 392
Buy 18 Jan 2024
Value US$276,068.80 | Price 0.80 | Shares 345,086
Buy 17 Jan 2024
Value US$235,195.30 | Price 0.78 | Shares 299,994
Buy 21 Nov 2023
Value US$66,700.00 | Price 0.67 | Shares 100,000
Buy 20 Nov 2023
Value US$215,400.00 | Price 0.72 | Shares 300,000
Sale 17 Nov 2023
Value US$328.65 | Price 0.69 | Shares 477
Sale 3 Oct 2023
Value US$1,879.29 | Price 0.80 | Shares 2,363
Sale 3 Oct 2023
Value US$1,503.91 | Price 0.80 | Shares 1,891
Sale 3 Oct 2023
Value US$1,503.91 | Price 0.80 | Shares 1,891
Proposed sale 3 Oct 2023
Value US$1,607.35 | Price 0.85 | Shares 1,891
Proposed sale 3 Oct 2023
Value US$2,008.55 | Price 0.85 | Shares 2,363
Sale 2 Aug 2023
Value US$10,292.62 | Price 1.09 | Shares 9,461
Sale 2 Aug 2023
Value US$12,866.59 | Price 1.09 | Shares 11,827
Proposed sale 2 Aug 2023
Value US$12,866.59 | Price 1.09 | Shares 11,827
Proposed sale 2 Aug 2023
Value US$10,292.62 | Price 1.09 | Shares 9,461
Sale 24 Jul 2023
Value US$900.38 | Price 1.07 | Shares 844
Sale 30 May 2023
Value US$4,046.22 | Price 0.96 | Shares 4,232
Proposed sale 30 May 2023
Value US$4,046.00 | Price 0.96 | Shares 4,232
Sale 23 May 2023
Value US$285.04 | Price 1.04 | Shares 274
Sale 23 May 2023
Value US$6,825.41 | Price 1.04 | Shares 6,561
Sale 23 May 2023
Value US$6,825.41 | Price 1.04 | Shares 6,561
Sale 23 May 2023
Value US$27,018.67 | Price 1.04 | Shares 25,972
Proposed sale 23 May 2023
Value US$6,825.00 | Price 1.04 | Shares 6,561
Proposed sale 23 May 2023
Value US$6,825.00 | Price 1.04 | Shares 6,561
Proposed sale 23 May 2023
Value US$27,019.00 | Price 1.04 | Shares 25,972
Sale 27 Mar 2023
Value US$4,784.98 | Price 1.02 | Shares 4,693
Planned sale 8 Aug 2022
Value US$26,200.50 | Price 2.13 | Shares 12,314
Planned sale 25 Jul 2022
Value US$4,479.15 | Price 2.22 | Shares 2,020
Planned sale 31 May 2022
Value US$8,004.87 | Price 1.92 | Shares 4,164
Planned sale 28 Mar 2022
Value US$10,362.86 | Price 2.24 | Shares 4,617
Planned sale 27 May 2021
Value US$16,637.39 | Price 4.03 | Shares 4,129
Planned sale 14 Dec 2020
Value US$7,982.78 | Price 6.15 | Shares 1,297
Planned sale 9 Nov 2020
Value US$22,403.59 | Price 5.10 | Shares 4,397
Planned sale 7 Aug 2020
Value US$17,009.62 | Price 22.50 | Shares 756
Planned sale 7 Aug 2020
Value US$247,907.34 | Price 21.76 | Shares 11,395
Planned sale 31 Mar 2020
Value US$117,523.73 | Price 15.04 | Shares 7,812
Planned sale 30 Mar 2020
Value US$17,830.88 | Price 14.22 | Shares 1,254
Planned sale 13 Dec 2019
Value US$30,661.61 | Price 21.00 | Shares 1,460
Planned sale 12 Dec 2019
Value US$826,577.90 | Price 25.00 | Shares 33,061
Planned sale 6 Sep 2018
Value US$13,442.02 | Price 40.01 | Shares 336
Planned sale 5 Sep 2018
Value US$609,546.60 | Price 40.09 | Shares 15,204
Buy 19 Jul 2018
Value US$50,123.04 | Price 41.77 | Shares 1,200
Buy 19 Jul 2018
Value US$49,428.24 | Price 41.19 | Shares 1,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17 S Sale
2.4
Bjorkquist Jeanette M

PFO and PAO

Officer
25,396 +31.0%
14.44
US$591,080 		25,396 +31.0% 14.44 US$591,080
2026-03-31 2026-03-30 S Sale
2.4
Bjorkquist Jeanette M

PFO and PAO

Officer
29,762 +4.3%
401.12
US$1,690,263 		29,762 +4.3% 401.12 US$1,690,263
2026-03-31 2026-03-30 S Sale
2.4
Bjorkquist Jeanette M

PFO and PAO

Officer
23,372 +46.4%
106.07
US$3,662,067 		23,372 +46.4% 106.07 US$3,662,067
2026-03-31 2026-03-30 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
9 -0.0%
27.49
US$247 		9 -0.0% 27.49 US$247
2026-03-31 2026-03-30 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
188 -0.5%
26.65
US$5,010 		188 -0.5% 26.65 US$5,010
2025-04-15 2025-03-31 S Sale
2.2
McHutchison John G
Non-Executive Director
757 -4.0%
9.85
US$7,455 		757 -4.0% 9.85 US$7,455
2025-04-01 2025-03-31 PlS Planned sale
2.5
Okazaki Jason A

CEO and President

Executive Director
355 -2.3%
9.85
US$3,496 		355 -2.3% 9.85 US$3,496
2025-04-01 2025-03-31 S Sale
2.4
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
180 -3.8%
9.85
US$1,773 		180 -3.8% 9.85 US$1,773
2025-04-01 2025-03-31 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
197 -1.7%
9.85
US$1,940 		197 -1.7% 9.85 US$1,940
2024-12-31 2024-12-30 B Purchase
0.6
Houghton Michael
Non-Executive Director
3,202 +inf%
15.61
US$49,998 		3,202 +inf% 15.61 US$49,998
2024-12-23 2024-12-19 B Purchase
1.3
GILEAD SCIENCES, INC.
Large shareholder
940,499 +74.1%
21.37
US$20,098,464 		940,499 +74.1% 21.37 US$20,098,464
2024-11-26 2024-11-25 B Purchase
4.0
Schornstein Alexander
Large shareholder
5,000 +0.7%
14.85
US$74,250 		5,000 +0.7% 14.85 US$74,250
2024-11-26 2024-11-25 B Purchase
4.0
Schornstein Alexander
Large shareholder
2,976 +0.4%
15.00
US$44,640 		2,976 +0.4% 15.00 US$44,640
2024-11-26 2024-11-22 B Purchase
4.0
Schornstein Alexander
Large shareholder
17,024 +2.4%
14.87
US$253,104 		17,024 +2.4% 14.87 US$253,104
2024-11-19 2024-11-18 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
40 -0.3%
16.29
US$652 		40 -0.3% 16.29 US$652
2024-10-09 2024-10-08 B Purchase
4.0
Schornstein Alexander
Large shareholder
10,000 +1.4%
14.58
US$145,800 		10,000 +1.4% 14.58 US$145,800
2024-10-04 2024-10-03 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
197 -1.3%
14.81
US$2,918 		197 -1.3% 14.81 US$2,918
2024-10-04 2024-10-03 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
157 -1.3%
14.81
US$2,325 		157 -1.3% 14.81 US$2,325
2024-08-05 2024-08-02 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
785 -6.1%
14.23
US$11,173 		785 -6.1% 14.23 US$11,173
2024-08-05 2024-08-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
981 -6.1%
14.23
US$13,962 		981 -6.1% 14.23 US$13,962
2024-07-08 2024-07-05 B Purchase
4.0
Schornstein Alexander
Large shareholder
4,438 +0.6%
12.52
US$55,564 		4,438 +0.6% 12.52 US$55,564
2024-07-08 2024-07-03 B Purchase
4.0
Schornstein Alexander
Large shareholder
4,562 +0.7%
12.29
US$56,067 		4,562 +0.7% 12.29 US$56,067
2024-05-24 2024-05-23 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
172 -1.3%
14.93
US$2,569 		172 -1.3% 14.93 US$2,569
2024-05-24 2024-05-23 PlS Planned sale
2.5
Okazaki Jason A

CEO and President

Executive Director
549 -3.3%
14.93
US$8,199 		549 -3.3% 14.93 US$8,199
2024-05-24 2024-05-23 S Sale
2.4
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
24 -0.8%
14.93
US$358 		24 -0.8% 14.93 US$358
2024-05-24 2024-05-23 S Sale
2.2
McHutchison John G
Non-Executive Director
2,117 -10.0%
14.93
US$31,615 		2,117 -10.0% 14.93 US$31,615
2024-05-01 2024-04-30 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
1,569 -8.7%
12.71
US$19,937 		1,569 -8.7% 12.71 US$19,937
2024-05-01 2024-04-30 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
1,255 -8.8%
12.71
US$15,947 		1,255 -8.8% 12.71 US$15,947
2024-04-02 2024-04-01 S Sale
2.4
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
114 -3.5%
13.07
US$1,490 		114 -3.5% 13.07 US$1,490
2024-04-02 2024-04-01 S Sale
2.2
McHutchison John G
Non-Executive Director
1,206 -5.4%
13.07
US$15,765 		1,206 -5.4% 13.07 US$15,765
2024-04-02 2024-04-01 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
197 -1.8%
13.07
US$2,575 		197 -1.8% 13.07 US$2,575
2024-04-02 2024-04-01 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
354 -2.5%
13.07
US$4,627 		354 -2.5% 13.07 US$4,627
2024-03-29 2024-03-27 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
392 -2.7%
12.87
US$5,045 		392 -2.7% 12.87 US$5,045
2024-01-19 2024-01-18 B Purchase
4.0
Schornstein Alexander
Large shareholder
345,086 +4.4%
0.80
US$276,069 		345,086 +4.4% 0.80 US$276,069
2024-01-19 2024-01-17 B Purchase
4.0
Schornstein Alexander
Large shareholder
299,994 +4.0%
0.78
US$235,195 		299,994 +4.0% 0.78 US$235,195
2023-11-22 2023-11-21 B Purchase
4.0
Schornstein Alexander
Large shareholder
100,000 +1.3%
0.67
US$66,700 		100,000 +1.3% 0.67 US$66,700
2023-11-22 2023-11-20 B Purchase
4.0
Schornstein Alexander
Large shareholder
300,000 +4.2%
0.72
US$215,400 		300,000 +4.2% 0.72 US$215,400
2023-11-21 2023-11-17 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
477 -0.5%
0.69
US$329 		477 -0.5% 0.69 US$329
2023-10-04 2023-10-03 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
2,363 -1.3%
0.80
US$1,879 		2,363 -1.3% 0.80 US$1,879
2023-10-04 2023-10-03 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
1,891 -1.2%
0.80
US$1,504 		1,891 -1.2% 0.80 US$1,504
2023-10-04 2023-10-03 S Sale
2.1
White Nicole S

Chief Manufacturing Officer

Officer
1,891 -2.0%
0.80
US$1,504 		1,891 -2.0% 0.80 US$1,504
2023-10-03 2023-10-03 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
1,891
0.85
US$1,607 		1,891 0.85 US$1,607
2023-10-03 2023-10-03 PrS Proposed sale
2.5
Jason A. Okazaki

Officer; Director

Executive Director
2,363
0.85
US$2,009 		2,363 0.85 US$2,009
2023-08-03 2023-08-02 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
9,461 -6.2%
1.09
US$10,293 		9,461 -6.2% 1.09 US$10,293
2023-08-03 2023-08-02 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
11,827 -6.7%
1.09
US$12,867 		11,827 -6.7% 1.09 US$12,867
2023-08-02 2023-08-02 PrS Proposed sale
2.5
Jason Okazaki

Officer; Director

Executive Director
11,827
1.09
US$12,867 		11,827 1.09 US$12,867
2023-08-02 2023-08-02 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
9,461
1.09
US$10,293 		9,461 1.09 US$10,293
2023-07-25 2023-07-24 S Sale
2.4
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
844 -3.1%
1.07
US$900 		844 -3.1% 1.07 US$900
2023-05-31 2023-05-30 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,232 -3.6%
0.96
US$4,046 		4,232 -3.6% 0.96 US$4,046
2023-05-30 2023-05-30 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
4,232
0.96
US$4,046 		4,232 0.96 US$4,046
2023-05-24 2023-05-23 S Sale
2.4
Bjorkquist Jeanette M

Principal Accounting Officer

Officer
274 -1.0%
1.04
US$285 		274 -1.0% 1.04 US$285
2023-05-24 2023-05-23 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
6,561 -4.9%
1.04
US$6,825 		6,561 -4.9% 1.04 US$6,825
2023-05-24 2023-05-23 S Sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
6,561 -5.3%
1.04
US$6,825 		6,561 -5.3% 1.04 US$6,825
2023-05-24 2023-05-23 S Sale
2.2
McHutchison John G
Non-Executive Director
25,972 -13.3%
1.04
US$27,019 		25,972 -13.3% 1.04 US$27,019
2023-05-23 2023-05-23 PrS Proposed sale
3.2
William E. Delaney IV

Officer

Officer
6,561
1.04
US$6,825 		6,561 1.04 US$6,825
2023-05-23 2023-05-23 PrS Proposed sale
2.5
Jason Okazaki

Officer; Director

Executive Director
6,561
1.04
US$6,825 		6,561 1.04 US$6,825
2023-05-23 2023-05-23 PrS Proposed sale
2.2
John G. McHutchison

Director

Non-Executive Director
25,972
1.04
US$27,019 		25,972 1.04 US$27,019
2023-03-28 2023-03-27 S Sale
2.5
Okazaki Jason A

CEO and President

Executive Director
4,693 -4.4%
1.02
US$4,785 		4,693 -4.4% 1.02 US$4,785
2022-08-10 2022-08-08 PlS Planned sale
2.2
McHutchison John G

Chief Executive Officer

Executive Director
12,314 -6.0%
2.13
US$26,200 		12,314 -6.0% 2.13 US$26,200
2022-07-26 2022-07-25 PlS Planned sale
Samar Michael P.

Chief Financial Officer

Officer
2,020 -2.5%
2.22
US$4,479 		2,020 -2.5% 2.22 US$4,479
2022-06-02 2022-05-31 PlS Planned sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,164 -5.2%
1.92
US$8,005 		4,164 -5.2% 1.92 US$8,005
2022-03-29 2022-03-28 PlS Planned sale
2.5
Okazaki Jason A

Chief Operating Officer

Officer
4,617 -6.7%
2.24
US$10,363 		4,617 -6.7% 2.24 US$10,363
2021-06-01 2021-05-27 PlS Planned sale
3.2
Delaney William E IV

Chief Scientific Officer

Officer
4,129 -7.2%
4.03
US$16,637 		4,129 -7.2% 4.03 US$16,637
2020-12-15 2020-12-14 PlS Planned sale
Papkoff Jacqueline Sybil

SVP-CSO Microbiome

Officer
1,297 -3.4%
6.15
US$7,983 		1,297 -3.4% 6.15 US$7,983
2020-11-10 2020-11-09 PlS Planned sale
Stamm Luisa M

Chief Medical Officer

Officer
4,397 -36.6%
5.10
US$22,404 		4,397 -36.6% 5.10 US$22,404
2020-08-10 2020-08-07 PlS Planned sale
2.2
McHutchison John G

CEO and President

Executive Director
756 -0.5%
22.50
US$17,010 		756 -0.5% 22.50 US$17,010
2020-08-10 2020-08-07 PlS Planned sale
2.2
McHutchison John G

CEO and President

Executive Director
11,395 -7.6%
21.76
US$247,907 		11,395 -7.6% 21.76 US$247,907
2020-03-31 2020-03-31 PlS Planned sale
Colonno Richard James

EVP & CSO, Virology Ops

Officer
7,812 -5.4%
15.04
US$117,524 		7,812 -5.4% 15.04 US$117,524
2020-03-31 2020-03-30 PlS Planned sale
Papkoff Jacqueline Sybil

SVP-CSO Microbiome

Officer
1,254 -3.1%
14.22
US$17,831 		1,254 -3.1% 14.22 US$17,831
2019-12-16 2019-12-13 PlS Planned sale Papkoff Jacqueline Sybil

SVP-CSO Microbiome

Officer
1,460 -6.0%
21.00
US$30,662 		1,460 -6.0% 21.00 US$30,662
2019-12-16 2019-12-12 PlS Planned sale Colonno Richard James

EVP & CSO, Virology Ops

Officer
33,061 -20.5%
25.00
US$826,578 		33,061 -20.5% 25.00 US$826,578
2018-09-07 2018-09-06 PlS Planned sale Lopatin Uri A

Chief Med. Off., VP Res. Dev.

Officer
336 -0.1%
40.01
US$13,442 		336 -0.1% 40.01 US$13,442
2018-09-07 2018-09-05 PlS Planned sale Lopatin Uri A

Chief Med. Off., VP Res. Dev.

Officer
15,204 -2.4%
40.09
US$609,547 		15,204 -2.4% 40.09 US$609,547
2018-07-20 2018-07-19 B Purchase Small Derek A

CEO and President

Executive Director
1,200 +0.2%
41.77
US$50,123 		1,200 +0.2% 41.77 US$50,123
2018-07-20 2018-07-19 B Purchase Small Derek A

CEO and President

Executive Director
1,200 +0.2%
41.19
US$49,428 		1,200 +0.2% 41.19 US$49,428
Explore more

More insider trading research around Assembly Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America